AI article
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Publisher description: AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
TechCrunch | Jan 13, 2026 | Kate Park
Automated excerpt
First, a generative model creates novel antibodies. Converge has completed over 40 programs with more than a dozen pharmaceutical and biotech customers, Gertz said. AI-driven drug discovery is experiencing a surge of interest.
Selected automatically from source text; not independently written or fact-checked. Read the original for full context.